Extracorporeal Membrane Oxygenation Versus Mechanical Ventilation Alone in Adults with Severe Acute Respiratory Distress Syndrome: A Systematic Review and Meta‐analysis
Youfeng Zhu,Min Zhang,Rui Zhang,Xiaoling Ye,Jianrui Wei
DOI: https://doi.org/10.1111/ijcp.14046
IF: 2.6
2021-01-01
International Journal of Clinical Practice
Abstract:International Journal of Clinical PracticeVolume 75, Issue 9 e14046 META-ANALYSIS Extracorporeal membrane oxygenation versus mechanical ventilation alone in adults with severe acute respiratory distress syndrome: A systematic review and meta-analysis Youfeng Zhu, Youfeng Zhu orcid.org/0000-0001-6793-5511 Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, ChinaSearch for more papers by this authorMin Zhang, Min Zhang Department of Geriatrics, The affiliated hospital of Qingdao University, Qingdao, ChinaSearch for more papers by this authorRui Zhang, Rui Zhang Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, ChinaSearch for more papers by this authorXiaoling Ye, Xiaoling Ye Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, ChinaSearch for more papers by this authorJianrui Wei, Corresponding Author Jianrui Wei Jianruiw@163.com Guangzhou Women and Children's Medical Center, Guangzhou, China Correspondence Jianrui Wei, Guangzhou Women and Children's Medical Center, No. 9 Jinsui Road, Guangzhou 510220, Guangdong, China. Email: Jianruiw@163.comSearch for more papers by this author Youfeng Zhu, Youfeng Zhu orcid.org/0000-0001-6793-5511 Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, ChinaSearch for more papers by this authorMin Zhang, Min Zhang Department of Geriatrics, The affiliated hospital of Qingdao University, Qingdao, ChinaSearch for more papers by this authorRui Zhang, Rui Zhang Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, ChinaSearch for more papers by this authorXiaoling Ye, Xiaoling Ye Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, ChinaSearch for more papers by this authorJianrui Wei, Corresponding Author Jianrui Wei Jianruiw@163.com Guangzhou Women and Children's Medical Center, Guangzhou, China Correspondence Jianrui Wei, Guangzhou Women and Children's Medical Center, No. 9 Jinsui Road, Guangzhou 510220, Guangdong, China. Email: Jianruiw@163.comSearch for more papers by this author First published: 24 January 2021 https://doi.org/10.1111/ijcp.14046Citations: 2 Youfeng Zhu and Min Zhang contributed equally to this work and are considered co-first authors. Funding information: This study was supported by the Science and Technology Program of Guangzhou (201904010258). The funding bodies were not involved in the design of the study; collection, analysis and interpretation of data; and writing the manuscript. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract Background COVID-19 can lead to acute respiratory distress syndrome (ARDS). Extracorporeal membrane oxygenation (ECMO) is considered to be a salvage strategy for severe ARDS. However, the effect of ECMO therapy on severe ARDS remains inconclusive. We aimed to evaluate the effects of ECMO for adults with severe ARDS. Methods We searched six databases (EMBASE, Medline, the Cochrane Library, Web of Science, Wanfang databases and CNKI) from inception to May 2020 to screen relevant high-quality observational studies and randomised controlled trials. We used the random effects model for outcome calculation. Trial sequential analysis (TSA), heterogeneity, sensitivity analysis and publication bias were explored. The primary outcome was 90-day mortality. Results Seven studies (two RCTs and five observational studies) with a total of 867 patients were included. Compared with MV therapy alone, ECMO therapy significantly reduced the mortality at 90 days (based on RCT studies, Risk Ratio [RR] 0.74, 95% confidence Interval (CI) 0.59-0.93, P = .01, I2 = 0%, moderate quality; based on observational studies, RR 0.61, 95% CI 0.46-0.81, P < .001, I2 = 0%, low quality) and at 30 and 60 days. TSA results were consistent with the primary outcome. Furthermore, device-related adverse events were similar between the ECMO group and MV alone group (RR, 2.09; 95% CI, 0.27-16.03, P = .48, I2 = 0%, moderate quality). Conclusions This study showed that the ECMO group exhibited a significantly lower mortality rate compared with the MV alone group at 90, 30 and 60 days for severe ARDS patients. Open Research DATA AVAILABILITY STATEMENT The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Citing Literature Supporting Information Filename Description ijcp14046-sup-0001-Supinfo.docWord document, 113.5 KB Supplementary Material Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume75, Issue9September 2021e14046 RelatedInformation